The Effects of Karvonen Exercise Prescription in Acute Coronary Artery Disease Patients Reaching Age-Predicted Maximal Heart Rates with Exercise Stress Test

  • Kim, Chul (Department of Rehabilitation Medicine, Sanggye-Paik Hospital) ;
  • Kim, Young-Joo (Department of Rehabilitation Medicine, Sanggye-Paik Hospital)
  • Received : 2013.04.03
  • Accepted : 2013.09.16
  • Published : 2013.09.30

Abstract

The purpose of this study was to survey the effects of Karvonen exercise prescription in coronary artery disease patients reaching age-predicted maximal heart rates with the exercise stress test on hemodynamic responses and cardiorespiratory fitness. The subject group was comprised of acute coronary syndrome (ACS) patients, who were divided into the maximal heart rate (MHR) group that included those who completed the test with their heart rates reaching the number of 220-age and the maximal dyspnea (MD) group that included those who could not continue the test due to respiratory difficulty and were asked to stop the test. Both groups had the exercise stress test before and after the experiment. In the exercise stress test before the experiment, the exercise prescription intensity of Karvonen was set at the target heart rates of 50~85% with a six-week exercise monitoring arrangement. As a result, there were no interactive effects in rest heart rate (RHR) according to time and group, but interactive effects were observed in maximal heart rate (MHR) (P=0.000). Both rest systolic blood pressure (RSBP) and rest diastolic blood pressure (RDBP) had no interactive effects according to time and group. Maximal systolic blood pressure (MSBP) showed significant interactive effects according to time and group (P=0.017). Maximal diastolic blood pressure (MDBP) showed no interactive effects according to time and group, while maximal rate pressure product (MRPP) showed significant interactive effects according to time and group (P=0.003). Maximal time (MT) had no interactive effects according to time and group. $VO_{2max}$ and maximal metabolic equivalent (MMET) showed significant interactive effects according to time and group (P=0.000, P=0.002, respectively), whereas maximal respiratory exchange ratio (MRER) and maximal rating of perceived exertion (MRPE) showed no interactive effects according to time and group. The exercise test that was discontinued as the subjects reached the predicted maximal heart rates considering age did not reach the maximal exercise intensity and accordingly showed low exercise effects when applied to Karvonen exercise prescription intensity. That is, the test should keep going by monitoring cardiac events, MRER and MRPE until the heart rates exceed the predicted MHR by up to 10~12 even after the subject reaches the predicted MHR considering age in the exercise stress test.

Keywords

References

  1. Ades PA. Cardiac rehabilitation and secondary prevention of coronary heart disease. NEJM. 2001. 345: 892-902. https://doi.org/10.1056/NEJMra001529
  2. American College of Sports Medicine. ACSM' s Guidelines for Exercise Testing and Prescription. 8th ed. Philadelphia, PA: 2009. pp. 319-326. Lippincott Williams & Wilkins, USA.
  3. American College of Sports Medicine. ACSM' s Guidelines for Exercise Testing and Prescription. 8th ed. Philadelphia, PA: 2009. pp. 202. Lippincott Williams & Wilkins, USA.
  4. Dorn J, Naughton J, Imamura D, Trevisan M. Results of a multicenter randomized clinical trial of exercise and longterm survival in myocardial infartion paients. The National Exercise and Heart Disease Project (NEHDP). Circulation. 1999. 100: 1764-1769. https://doi.org/10.1161/01.CIR.100.17.1764
  5. Gibobons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL Jr, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC Jr. Pretest likelihood of atherosclerotic cardiovascular disease (CVD), ACC/AHA 2002 Guideline Update for Exercise Testing a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Committee on Exercise Testing. Circulation. 2002. 106: 1883-1892. https://doi.org/10.1161/01.CIR.0000034670.06526.15
  6. Karvonen MJ, Kentala E, Mustala O. The effect of training on heart rate: a longitudinal study. Ann Med Exp Biol Fenn. 1957. 35: 307-315.
  7. Kligfield P, Lauer MS. Exercise electrocardiogram testing: beyond the ST segment. Circulation. 2006. 114: 2070-2082. https://doi.org/10.1161/CIRCULATIONAHA.105.561944
  8. Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, Fleg J, Froelicher VF, Leon AS, Pina IL, Rodney R, Simonsmorton DA, Williams MA, Bazzrarre T. Exercise standards for testing and training: a statement for healthcare professions from the American Heart Association. Circulation. 2003. 104: 1694-1740.
  9. Lauer MS, Sivarajan-Froelicher E, Williams M, Kligfield P. Exercise testing in asymptomatic adults. a statement for health professionals from the American Heart Association Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitaion, and Prevention. Circulation. 2005. 112: 771-776. https://doi.org/10.1161/CIRCULATIONAHA.105.166543
  10. Laukkanen JA, Kurl S, Salonen R, Rauramaa F, Salonen JT. The predictive value of cardiorespiratory fitness for cardiovascular events in men with various risk profiles: A prospective popula- tion-based cohort study. Eur Heart J. 2004. 25: 1428-1437. https://doi.org/10.1016/j.ehj.2004.06.013
  11. Lavie CJ, Milani RV. Effects of cardiac rehabilitation and exercise training on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in women. Am J Cardiol. 1995. 75: 340-343. https://doi.org/10.1016/S0002-9149(99)80550-5
  12. Lavie CJ, Thomas RJ, Squires RW, Allison TG, Milani RV. Exercise training and cardiac rehabilitation in primary and secondary prevention of coronary heart disease. Mayo Clinic Proc. 2009. 34: 373-383.
  13. Leon AS, Franklin BA, Costa F, Balady GJ, Berra KA, Stewart KJ, Thompson PD, Williams MA, Lauer MS. Cardiac rehabilitation and secondary prevention of coronary heart disease. Circulation. 2005. 111: 369-376. https://doi.org/10.1161/01.CIR.0000151788.08740.5C
  14. Londeree BR, Moeschberger ML. Influence of age and other factors on maximal heart rate. J Cardiac Rehab. 1984. 4: 44-49.
  15. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002. 346: 793-801. https://doi.org/10.1056/NEJMoa011858
  16. Pederson O, Beck-Nielsen H, Heding L. Increased insulin receptors after exercise in patients with insulin-dependent diabetes mellitus. N Engl J Med. 1980. 302: 886-892. https://doi.org/10.1056/NEJM198004173021603
  17. Moholdt T, Aamot IL, Granoien I, Gjerde L, Myklebust G, Walderhaug L, Brattbakk L, Hole T, Graven T, Stolen TO, Amundsen BH, Molmen-Hansen HE, Stoylen A, Wisloff U, Slordahl SA. Aerobic interval training increases peak oxygen uptake more than usual care exercise training in myocardial infarction patients: a randomized controlled study. Clin Rehabil. 2011. 26: 33-44.
  18. Munk PS, Staal EM, Butt N, Isaksen K, Larsen AI. High-intensity interval training may reduce in-stent restenosis following percutaneous coronary intervention with stent implantation A randomized controlled trial evaluating the relationship to endothelial function and inflammation. Am Heart J. 2009. 158: 734-41. https://doi.org/10.1016/j.ahj.2009.08.021
  19. Vanhees L, Fagard R, Thijs L. Prognostic significance of peak exercise capacity in patients with coronary artery disease. Am J Cardiol. 1994. 23: 358-363. https://doi.org/10.1016/0735-1097(94)90420-0
  20. Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM, Tjonna AE, Helgerud J, Slordahl SA, Lee SJ, Videm V, Bye A, Smith GL, Najjar SM, Ellingsen O, Skjaerpe T. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation. 2007. 115: 3086-94. https://doi.org/10.1161/CIRCULATIONAHA.106.675041